Bamco Inc. NY Buys 133,000 Shares of Stevanato Group S.p.A. (NYSE:STVN)

Bamco Inc. NY grew its position in shares of Stevanato Group S.p.A. (NYSE:STVN - Free Report) by 7.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,818,181 shares of the company's stock after acquiring an additional 133,000 shares during the quarter. Bamco Inc. NY owned about 0.60% of Stevanato Group worth $39,618,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also bought and sold shares of STVN. Van Berkom & Associates Inc. bought a new stake in Stevanato Group in the 4th quarter worth about $39,000. Johnson Financial Group Inc. purchased a new stake in shares of Stevanato Group during the 4th quarter valued at $41,000. Wells Fargo & Company MN boosted its holdings in shares of Stevanato Group by 680.3% in the 4th quarter. Wells Fargo & Company MN now owns 3,246 shares of the company's stock worth $71,000 after buying an additional 2,830 shares during the last quarter. PNC Financial Services Group Inc. raised its position in Stevanato Group by 1,457.6% in the fourth quarter. PNC Financial Services Group Inc. now owns 5,654 shares of the company's stock worth $123,000 after acquiring an additional 5,291 shares during the period. Finally, Tower Research Capital LLC TRC grew its position in shares of Stevanato Group by 202.8% during the 4th quarter. Tower Research Capital LLC TRC now owns 7,413 shares of the company's stock valued at $162,000 after acquiring an additional 4,965 shares during the period.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on STVN shares. UBS Group dropped their price target on Stevanato Group from $24.00 to $23.50 and set a "neutral" rating on the stock in a research report on Friday, March 7th. Stephens upgraded Stevanato Group to a "strong-buy" rating in a research report on Monday, April 21st. Finally, William Blair reaffirmed an "outperform" rating on shares of Stevanato Group in a report on Friday, March 7th. Two research analysts have rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of €25.70 ($28.88).

Stevanato Group Price Performance

NYSE STVN traded up €0.61 ($0.69) on Thursday, reaching €22.41 ($25.18). 394,700 shares of the company's stock traded hands, compared to its average volume of 347,192. The stock has a market cap of $6.79 billion, a PE ratio of 47.68, a P/E/G ratio of 7.18 and a beta of 0.51. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.81 and a quick ratio of 1.21. Stevanato Group S.p.A. has a 12 month low of €16.56 ($18.61) and a 12 month high of €24.90 ($27.98). The stock has a 50-day simple moving average of €20.94 and a 200 day simple moving average of €20.93.

Stevanato Group (NYSE:STVN - Get Free Report) last issued its earnings results on Thursday, March 6th. The company reported €0.20 ($0.22) EPS for the quarter, hitting analysts' consensus estimates of €0.20 ($0.22). Stevanato Group had a net margin of 10.47% and a return on equity of 9.86%. The company had revenue of €352.68 million for the quarter, compared to analysts' expectations of €346.26 million. As a group, research analysts predict that Stevanato Group S.p.A. will post 0.5 earnings per share for the current year.

Stevanato Group Increases Dividend

The company also recently disclosed an annual dividend, which will be paid on Thursday, July 17th. Stockholders of record on Thursday, June 5th will be paid a dividend of $0.0613 per share. This represents a dividend yield of 0.3%. This is an increase from Stevanato Group's previous annual dividend of $0.05. The ex-dividend date is Thursday, June 5th. Stevanato Group's dividend payout ratio is 12.50%.

Stevanato Group Company Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.